Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
about
Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solutionThe Structural Basis of Action of Vanadyl (VO(2+)) Chelates in Cells.Phosphorylation-dependent changes in structure and dynamics in ERK2 detected by SDSL and EPR.The anti-diabetic bis(maltolato)oxovanadium(IV) decreases lipid order while increasing insulin receptor localization in membrane microdomains.Reactivity-activity relationships of oral anti-diabetic vanadium complexes in gastrointestinal media: an X-ray absorption spectroscopic study.Vanadium compounds modulate PPARγ activity primarily by increasing PPARγ protein levels in mouse insulinoma NIT-1 cells.Interaction of [VIV O(acac)2 ] with Human Serum Transferrin and Albumin.Bis(acetylacetonato)-oxidovanadium(IV) and sodium metavanadate inhibit cell proliferation via ROS-induced sustained MAPK/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells.Stabilities and Biological Activities of Vanadium Drugs: What is the Nature of the Active Species?Vanadyl bisacetylacetonate protects β cells from palmitate-induced cell death through the unfolded protein response pathway.Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.Structural origins of the insulin-mimetic activity of bis(acetylacetonato)oxovanadium(IV).Structural characterization and DFT study of V(IV)O(acac)2 in imidazolium ionic liquids.Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO2+) chelates.VIVO complexes with antibacterial quinolone ligands and their interaction with serum proteins.
P2860
Q33548459-9D0C360F-2A13-4963-931B-30138F86CC4AQ34180436-10BB404C-5FF7-4C76-85FB-D625E132695FQ34184324-DEDBD80B-E32B-4A87-87D4-A04FA8BBFFDFQ34262663-85AEB3F5-7ED4-43F0-B5C1-0BB024539081Q35220583-46B16C0A-70C5-4868-BDB8-A67A2BDF0580Q38317361-983AF7EF-C80E-4B17-8012-5F4235283B83Q38708683-FBF4EFB7-EF46-4692-B6D9-D964755B0844Q38747030-9E31D5E8-C1FB-4CAC-B529-B298B6067E68Q39237165-5F9F3F88-B5CB-4296-9D84-E6B9DFC1EDE8Q39554713-B36D84E8-C9FC-4296-8C87-C96B5F8CB5EBQ39747431-071A50A1-2AA1-43A4-A5F2-F9D1AD30CEBAQ42819203-C99BEE18-DBD6-4B0A-9E7C-43BC82FAEC36Q46068345-1E6F2B43-234B-49C5-9078-C89D96F4CF14Q46931570-0068DB1A-354B-4702-8BDF-0F9156DA5D24Q47602319-57809361-AB67-4EC8-AB09-7E524C449141Q47720108-985651F6-0BFB-4C95-A4DA-071D013D182C
P2860
Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chemistry and insulin-mimetic ...... ovanadium(IV) and derivatives.
@ast
Chemistry and insulin-mimetic ...... ovanadium(IV) and derivatives.
@en
type
label
Chemistry and insulin-mimetic ...... ovanadium(IV) and derivatives.
@ast
Chemistry and insulin-mimetic ...... ovanadium(IV) and derivatives.
@en
prefLabel
Chemistry and insulin-mimetic ...... ovanadium(IV) and derivatives.
@ast
Chemistry and insulin-mimetic ...... ovanadium(IV) and derivatives.
@en
P2093
P356
P1433
P1476
Chemistry and insulin-mimetic ...... ovanadium(IV) and derivatives.
@en
P2093
Anderson OP
Brichard SM
P304
P356
10.1021/IC9905897
P407
P577
2000-02-01T00:00:00Z